00617pab a2200133 454500008004000000100001700040245006600057260000900123300001200132362000800144520030500152650001000457773001600467180718b1999   xxu||||| |||| 00| 0 eng d  aMirza, Zafar  aWTO/TRIPs, pharmaceuticals and health: impacts and strategies  c1999  ap.92-97  aDec  aZafar Mirza looks at the problems of high drug prices, low access to medicines and the weakening of the national pharmaceutical industry for the majority of the world's population when the `Agreement on Trade-Related Aspects of Intellectual Property Rights' (TRIPs) is to be implemented. - Reproduced  aDrugs  aDevelopment